Medirom Healthcare Technologies Inc.: Form 20-F for the period ended Dec 31, 2020
Filed with the SEC on May 17, 2021 and accepted by EDGAR at May 17, 2021, 10:15 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2020-01-01 to 2020-12-31 | JPY 3.34bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 12 months2020-01-01 to 2020-12-31 | JPY 1.07bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2020-01-01 to 2020-12-31 | −JPY 746.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2020-01-01 to 2020-12-31 | JPY 13.2m | us-gaap:InterestExpense |
| Income tax | 12 months2020-01-01 to 2020-12-31 | −JPY 87.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2020-01-01 to 2020-12-31 | −JPY 539.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2020-01-01 to 2020-12-31 | −JPY 133.97 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2020-01-01 to 2020-12-31 | −JPY 133.97 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2020-01-01 to 2020-12-31 | 4,024,692 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2020-01-01 to 2020-12-31 | −JPY 366.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2020-01-01 to 2020-12-31 | JPY 73.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2020-12-31 | JPY 2.09bn | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | JPY 5.71bn | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | JPY 2.65bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2020-12-31 | JPY 668.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2020-12-31 | JPY 242.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2020-12-31 | JPY 491.3m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2020-12-31 | 4,822,500 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001558370-21-007318. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.